Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2936 Neoplasms 2634 Lung Neoplasms 1371 Colorectal Neoplasms 1332 Prostatic Neoplasms 1216 Carcinoma, Non-Small-Cell Lung 1080 Carcinoma, Hepatocellular 784 Stomach Neoplasms 721 Pancreatic Neoplasms 704 Ovarian Neoplasms 586 Colonic Neoplasms 534 Uterine Cervical Neoplasms 497 Head and Neck Neoplasms 496 Rectal Neoplasms 472 Melanoma 467 Multiple Myeloma 463 Esophageal Neoplasms 423 Neoplasm Metastasis 418 Brain Neoplasms 405 Lymphoma 399 Precursor Cell Lymphoblastic Leukemia-Lymphoma 398 Urinary Bladder Neoplasms 387 Leukemia, Myeloid, Acute 387 Leukemia 339 Carcinoma, Renal Cell 329 Liver Neoplasms 320 Endometrial Neoplasms 319 Hematologic Neoplasms 313 Recurrence 298 Disease 275

Interventions

fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hypoxic Tumours × Clear all

NCT00756691 2017-11-14

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

AHS Cancer Control Alberta

Hypoxic Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡